Derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, preparation method and use thereof

A technology of JJA-D0 and berberine, applied in the field of medicine, can solve the problem of single site that can be modified by the parent compound

Active Publication Date: 2018-12-07
JINAN UNIVERSITY
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In the previous work, the berberine dimer has been synthesized in the prior art and is ready to be structurally modified, but the modified site of this parent compound is relatively single

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, preparation method and use thereof
  • Derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, preparation method and use thereof
  • Derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Embodiment 1: Compound Apo-NO 2 Synthesis

[0086] Take berberine (1.66g, 10mmol), add 10ml of glacial acetic acid to dissolve, slowly add 1.5ml of 67wt% concentrated nitric acid under ice bath stirring, react for 30min, remove ice water, react at room temperature for 3h, add to the system after the reaction Ice-water, suction-filtered to obtain a yellow solid, washed with ice-water, and recrystallized in 95% (v / v) ethanol to obtain yellow needle-like crystals (1.65 g, yield 78%). This compound is a known compound, which is consistent with the spectra recorded in the literature through mass spectrometry and nuclear magnetic spectrum.

Embodiment 2

[0087] Embodiment 2: Compound Apo-NH 2 Synthesis

[0088] Apo-NO 2 (2.11g, 10mmol) was dissolved in 30ml ethanol, and the mass ratio was added to be 10% Pd / C (950mg), and the reaction mixture was passed into H 2 Reacted overnight, washed with water after the reaction, took the organic layer and concentrated it under reduced pressure, and separated it on a silica gel column (ethyl acetate:petroleum ether=1:2) to obtain a light white solid Apo-NH 2 (1.32 g, 73% yield). This compound is a known compound, which is consistent with the spectra recorded in the literature through mass spectrometry and nuclear magnetic spectrum.

Embodiment 3

[0089] Embodiment 3: the synthesis of compound Apo-CHO

[0090] Put berberine (1.66g, 10mmol) in a flask, add a mixed solution of 3ml of triethylamine and 20ml of absolute ethanol, then drop 30ml of 50wt% sodium hydroxide aqueous solution into the system, stir and mix. Chloroform (5.95g, 50mmol) was added dropwise to the reaction solution, and reacted at 70-80°C for 2h. The reaction solution was cooled to room temperature and acidified to pH=1 with hydrochloric acid. The organic layer was collected, the aqueous layer was extracted with dichloromethane, the organic layers were combined and washed with water, dried over anhydrous sodium sulfate, concentrated, and separated on a silica gel column (ethyl acetate:petroleum ether=2:3) to obtain a light yellow powder Apo-CHO (0.69 g, 36% yield). This compound is a known compound, which is consistent with the spectra recorded in the literature through mass spectrometry and nuclear magnetic spectrum.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, a preparation method and use thereof. The compound has a structure shown as a general formula (I). According to the invention, an alkyl group, an aryl group, a heteroaryl group, an alkoxycarbonylalkyl group, an acyl group, a sulfonate group, an antioxidant group such as a lipoic acid group,a H2S donor group such as a cysteine group, and a NO donor group such as a nitrate group are introduced to JJA-D0, and a series of structurally novel compounds can be synthesized and disclosed. The compounds inhibit NADPH oxidase and have superior anti-oxidation and anti-inflammatory pharmacological mechanisms by comparing with Kutkin, the compounds also have donor groups that provide NO and H2S,can further enhance pharmacological activity, and can be a new class of multifunctional compounds. The disclosed JJA-D0 derivative can be used for preparing health products or drugs for prevention ortreatment of diseases associated with NADPH oxidase, diseases associated with free radicals, diseases associated with inflammation, diseases associated with NO, and diseases associated with H2S.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to derivatives of berberine dimer analog JJA-D0 or pharmaceutically acceptable salts thereof, preparation methods and applications. Background technique [0002] Berberine is the main active ingredient in Hu Huanglian, a commonly used traditional Chinese medicine. It was originally isolated from Apocynum Cannabinum L., and its structure is shown below. Huhuanglian is the rhizome of Tibet Huhuanglian and Huhuanglian, which are plants of the family Scrophulariaceae. Huhuanglian is mainly distributed in the Himalayas, and Tibetan Huhuanglian is mainly distributed in Sichuan, Yunnan, and Tibet. [0003] [0004] Molecular structure of berberine [0005] Huhuanglian is used in Indian folk for the treatment of gallbladder, antimalarial, spleen, urinary tract infection and hepatitis. With the in-depth study of its chemical components and pharmacological effects, it was found that ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C225/22C07C221/00C07D339/04C07C321/14C07C319/20C07C233/33C07C231/12C07C309/66C07C303/28C07C303/30C07C309/65A61P9/12A61P9/10A61P9/00A61P9/06A61P11/00A61P11/06A61P25/28A61P13/12A61P19/02A61P3/10A61P35/00A61P37/08A61P37/02A61P17/00A61P27/12A61P27/06A61P27/00A61P1/00A61P17/06A61P1/16A61P13/08A61P3/04A61P25/08A61P25/06A61P25/14A61P1/02
CPCC07C225/22C07C233/33C07C309/65C07C309/66C07C321/14C07D339/04
Inventor 蒋杰李沙藕洋高瑞涛张志坚王高芳祁健斌
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap